19.11.2020: As of today the Dynamic Dashboard shows data on the close to 1900 organisations from 64 countries across the world that receive funding for AMR R&D. This new expansion of the functionalities allows a detailed look at the global fabric of AMR R& D. Several existing reports in the Dynamic Dashboard now allow filtering by the type of research organisation. Access the report here.
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.